Isa tips for 2017: 10 shares for a £10,000 annual income

machine-churning-out-ten-pound-notes

Investors spent much of 2016 arguing about valuations, worrying that equities were just too expensive. But despite huge market shocks including the China-inspired crash, Brexit vote and Donald Trump's election win, share prices recovered each time with renewed vigour.

We shouldn't really be surprised. Where else is the public expected to invest its money? At a time of record-low interest rates, dividend-paying equities are catnip to income-seeking investors - even more so following the Bank of England's decision in August to halve rates to 0.25 per cent and beef up its programme of quantitative easing (QE).

Acknowledging the persistent difficulty of achieving decent returns on your money, we decided to build another portfolio of 10 companies able to generate annual dividend income of £10,000.

HOW DID WE DO IN 2016?

Our inaugural income portfolio in 2015 achieved its objective, give or take £80, and although it suffered some capital depreciation, it outperformed the FTSE 100 over the 12-month period. In 2016, having received a few tweaks, our portfolio did far better, and required less upfront capital too.

Our £176,270 portfolio generated £10,326 income in 2016 - a 5.8 per cent yield. That's more than expected, far outstripping the paltry rates paid on bank savings accounts and significantly above inflation. Capital appreciation of £14,000, or 8 per cent, was very generous icing on the cake.

Behind a significant slug of this outperformance were Royal Dutch Shell and HSBC, who both announce their dividends in dollars. Over the year the greenback surged by 16 per cent versus sterling, most of that in the aftermath of the EU referendum vote, which sent the pound to a 31-year low.

Converting those valuable dollars back into cheap pounds generated a windfall which, when added to the special dividend paid by GlaxoSmithKline, easily offset mildly over-optimistic dividend forecasts elsewhere in the portfolio. A 58 per cent share price gain in addition made Shell our star stock of 2016.

In most cases, the difference between what was predicted and what our companies paid was modest. However, support services and construction firm Interserve came in short, and the shares slumped in May after it took a big charge on a problem energy-to-waste contract in Glasgow.

Bicycles-to-car parts retailer Halfords had a cracking five months before a drop in annual profits and the Brexit vote put a spanner in the works. It still did well for us, however, generating a 15 per cent profit and 5.4 per cent yield.

With the FTSE 100 up 15 per cent and the FTSE All-Share index up 13 per cent in the past year, both to a record high, share price gains have outpaced dividend growth, eroding yields.

That might typically make it more expensive to generate £10,000 of annual income. However, by taking on a bit more risk, we've managed to build a portfolio to do it, and for even less than in previous years.

There are certainly plenty more challenges in 2017, most seriously Donald Trump's approach to the US presidency, Theresa May's determination to trigger Article 50 and the UK's withdrawal from the EU, and elections in France and Germany.

The FTSE 100's current crop of top-yielders is littered with strugglers, too, among them Pearson, Capita and Marks & Spencer. With oil prices on the up, a weak pound increasing costs for UK firms, and both rail fares and energy costs increasing sharply, inflation will rear its head in 2017.

Any pressure on consumer spending could easily feed through to vulnerable sectors such as retailers, airlines and pub companies. Unless conditions are severe, dividends should survive - but risk has increased nonetheless.

So, after weeding out the wrong 'uns, 6 per cent looks like a cracking yield this time round. By widening the net and placing confidence in resurgent sectors, we need upfront capital of just £168,500 this year.

PORTFOLIO RESHUFFLE

Half the portfolio gets the boot, some shares being the victim of their own success and others punished for underperformance or greater perceived risk of disappointment in future.

Shell falls into the first camp, following a sharp recovery in the oil price and pricing in the potentially lucrative acquisition of BG Group, which completed early in 2016.

Its dividend does remain generous, however, and Ben van Beurden will not want to be Shell's first chief executive to cut the payout since World War II.

If this were a multi-year portfolio we might have considered running the position, but as it begins afresh each year and Shell has made us a 58 per cent profit, BP is better value and the dividend is equally impressive.

Another company generating money from the black stuff makes the portfolio in 2017. Petrofac, a £3 billion oil services firm, equalled the market's performance in 2016, and big contract wins are tipped to recommence over the next few months.

Make no mistake, this is a spicy pick, but a forward price/earnings ratio of 9 and prospective dividend yield of over 6 per cent are worth it.

Defence giant BAE Systems earned its keep in 2016, and military fan Trump could be good for business. That said, the shares are no longer cheap, and we can get a better yield elsewhere.

A major beneficiary of the post-referendum rally, National Grid lost its way in November, and both a modest yield and flat share price performance over the 12 months have caused our eye to wander, but only as far as fellow utility SSE.

High energy prices could give a major boost to earnings at the Scottish power company, and we're assured that it's on track to keep its promise of annual dividend increases at least in line with retail prices index inflation, currently at 2.2 per cent but tipped to rise much further in 2017.

While Interserve's dividend looks safe, the shares are volatile and the yield insufficient to keep its place in the portfolio. Despite some wobbles, we still like Halfords, but a likely squeeze on consumer spending could cause sleepless nights.

Far better to call in mobile phone heavyweight Vodafone, which is on track to hit results forecasts and offer a dividend yield of well over 6 per cent. An increase in profits and declining spectrum costs should drive big improvements in return on capital and underpin the payout.

Last of the new constituents, and the riskiest of them all, is Alternative Investment Market-listed Premier Asset Management.

It only returned to Aim in October, nine years after a private equity-backed management buyout, and hasn't paid a dividend yet. But it will, beginning with returns for the three months to December.

And it can afford to be generous. Premier has over £5 billion of assets under management, has reported 14 consecutive quarters of net positive fund flows, is debt-free and profits are growing fast. A small investment here could be lucrative.

THE KEEPERS

Of the 10 companies in the 2016 portfolio, five keep their place in the new basket of dividend kings. Big-hitters HSBC, GlaxoSmithKline and Imperial Brands make it three years out of three. Significant dollar earnings are an obvious boon for all three while the pound remains under pressure.

For HSBC shareholders, the payment of dividends in dollars is also beneficial currently. Like last year, Glaxo promises an ordinary dividend of 80p in 2017 and Imperial has an impressive dividend track record.

And we still back Legal & General to fill up the coffers in 2017. A recession seems less likely now, and concerns that EU regulation will hurt the bulk annuities market look overdone.

The insurer and fund provider will also benefit from the increasing popularity of passive and exchange traded funds.

Finally, there's room for Barratt Developments again. Last year was awful, but it gives new investors a great chance to lock in a knockout dividend on the cheap.

A rebound from the post-referendum crash has also found fresh momentum, so, barring a catastrophe, there could be decent capital appreciation too.

isa-share-portfolio


Subscribe to Money Observer magazine

 

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.